Income Statement for XTL Biopharmaceuticals Ltd. (XTLB)

Income Statement for XTL Biopharmaceuticals Ltd.
Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Profit
Total Revenue 2,369,000 938,000 -
Cost of Revenue 741,000 380,000 -
Gross Profit 1,628,000 558,000 -
Operating Expenses
Research Development 113,000 99,000 158,000
Selling General and Administrative 2,680,000 2,815,000 1,066,000
Non Recurring 1,729,000 - -
Others - - -
Total Operating Expenses - - -
Operating Income or Loss -2,894,000 -2,356,000 -1,224,000
Income from Continuing Operations
Total Other Income/Expenses Net 61,000 60,000 24,000
Earnings Before Interest And Taxes -2,833,000 -2,296,000 -1,200,000
Interest Expense 35,000 15,000 7,000
Income Before Tax -2,868,000 -2,311,000 -1,207,000
Income Tax Expense - - -
Minority Interest - - -
Net Income From Continuing Ops -3,713,000 -1,742,000 -1,207,000
Non-recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect Of Accounting Changes - - -
Other Items - - -
Net Income
Net Income -3,713,000 -1,742,000 -1,207,000
Preferred Stock And Other Adjustments - - -
Net Income Applicable To Common Shares -3,713,000 -1,742,000 -1,207,000